Area of research
Oncology · Economics and Econometrics
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Economic and Financial Impacts of Cancer, Advances in Oncology and Radiotherapy, and Gastric Cancer Management and Outcomes.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
Common Sense Oncology: outcomes that matter
Training of oncologists: results of a global survey
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer